Baskhanbio Pharma Inc. (XKON:354390)
South Korea
· Delayed Price · Currency is KRW 3,980.00
-265.00 (-6.24%)
At close: Apr 28, 2025, 3:30 PM KST
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 28.04 billion as of May 2, 2025. Its market cap has decreased by -37.48% in one year.
Market Cap
28.04B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,980.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 28.04B, a decrease of -66.14%. That is a compound annual growth rate of -32.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 28.04B | -6.88% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 366.77T |
| SK hynix | 122.30T |
| LG Energy Solution | 75.93T |
| Samsung Biologics | 74.88T |
| Hyundai Motor Company | 41.74T |
| Hanwha Aerospace | 36.24T |
| HD Hyundai Heavy Industries | 35.82T |
| Kia Corporation | 35.59T |